Abbott Laboratories
Large Cap · Healthcare · Medical Devices
$114.75+$2.07 (+1.84%)
Abbott Laboratories
Large Cap · Healthcare · Medical Devices
$114.75+$2.07 (+1.84%)
Stock analysis
Get the AI take on ABT
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$81.97
High$137.49
Today $114.75
RSI (14)
84.7Overbought
03070100
Overall score
57/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Lowest
$103
Current price
$114.75
Median target
$120
Highest
$135
LowHigh
Operating Record
Revenue
What's working
- Forward P/E: Investors aren't pricing in much earnings growth, so there's room to be pleasantly surprised.
- Debt / equity: Light borrowing means a rough patch wouldn't threaten the balance sheet.
What to watch
- Debt exceeds cash by $27.1B, increasing balance-sheet pressure, a warning sign.
- ROIC: Capital plowed back into the business isn't earning much for its trouble.
What the market charges
Forward P/E
Favorable · 15% below avg
19.18x
Price / sales
Reasonable · Priced reasonably against its revenue
4.13x
Price / FCF
Reasonable · Priced a bit rich against its cash flow
24.60x
EV / EBITDA
Reasonable · Operating earnings make this price a stretch but plausible
18.80x
How efficiently it compounds
ROIC
Weak · Struggling to earn much on the capital it uses
7.5%
ROE
Middle ground · Mixed
10.6%
Debt / equity
Favorable · 0.65 - strong leverage
0.63x
Current ratio
Reasonable · Just enough on hand to cover near-term bills
1.38x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $192.51B | 36.0 | +8.1% | 57 |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |
